Annual Total Long Term Liabilities
$1.73 M
-$583.00 K-25.25%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual total long term liabilities is $1.73 million, with the most recent change of -$583.00 thousand (-25.25%) on December 31, 2023.
- During the last 3 years, CANF annual total long term liabilities has fallen by -$454.00 thousand (-20.83%).
- CANF annual total long term liabilities is now -67.91% below its all-time high of $5.38 million, reached on December 31, 2015.
Performance
CANF Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.46 M
-$270.00 K-15.64%
June 30, 2024
Summary
- As of February 7, 2025, CANF quarterly total long term liabilities is $1.46 million, with the most recent change of -$270.00 thousand (-15.64%) on June 30, 2024.
- Over the past year, CANF quarterly long term liabilities has dropped by -$469.00 thousand (-24.36%).
- CANF quarterly long term liabilities is now -78.20% below its all-time high of $6.68 million, reached on September 30, 2015.
Performance
CANF Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CANF Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.3% | -24.4% |
| 3 y3 years | -20.8% | -56.7% |
| 5 y5 years | -5.1% | +11.3% |
CANF Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.0% | at low | -53.6% | at low |
| 5 y | 5-year | -45.0% | at low | -59.6% | at low |
| alltime | all time | -67.9% | +9383.5% | -78.2% | +7900.0% |
Can-Fite BioPharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $1.46 M(-15.6%) |
| Dec 2023 | $1.73 M(-25.2%) | $1.73 M(+0.1%) |
| Sep 2023 | - | $1.72 M(-10.4%) |
| Jun 2023 | - | $1.93 M(-8.6%) |
| Mar 2023 | - | $2.10 M(-8.8%) |
| Dec 2022 | $2.31 M(-26.5%) | $2.31 M(-7.0%) |
| Sep 2022 | - | $2.48 M(-8.1%) |
| Jun 2022 | - | $2.70 M(-7.5%) |
| Mar 2022 | - | $2.92 M(-7.1%) |
| Dec 2021 | $3.14 M(+44.1%) | $3.14 M(-0.3%) |
| Sep 2021 | - | $3.15 M(-6.4%) |
| Jun 2021 | - | $3.37 M(-6.6%) |
| Mar 2021 | - | $3.60 M(+65.4%) |
| Dec 2020 | $2.18 M(-11.4%) | $2.18 M(+10.9%) |
| Sep 2020 | - | $1.97 M(-8.3%) |
| Jun 2020 | - | $2.14 M(-12.9%) |
| Dec 2019 | $2.46 M(+35.4%) | - |
| Dec 2019 | - | $2.46 M(+56.8%) |
| Sep 2019 | - | $1.57 M(+20.0%) |
| Jun 2019 | - | $1.31 M(-15.0%) |
| Mar 2019 | - | $1.54 M(-15.3%) |
| Dec 2018 | $1.82 M(+114.9%) | - |
| Dec 2018 | - | $1.82 M(-12.5%) |
| Sep 2018 | - | $2.08 M(-10.4%) |
| Jun 2018 | - | $2.32 M(-7.3%) |
| Mar 2018 | - | $2.50 M(+195.4%) |
| Dec 2017 | $846.00 K | - |
| Dec 2017 | - | $846.00 K(-78.4%) |
| Sep 2017 | - | $3.92 M(-15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $4.64 M(+3.1%) |
| Mar 2017 | - | $4.50 M(+18.7%) |
| Dec 2016 | $3.79 M(-29.5%) | - |
| Dec 2016 | - | $3.79 M(-11.7%) |
| Sep 2016 | - | $4.29 M(-2.7%) |
| Jun 2016 | - | $4.41 M(-12.3%) |
| Mar 2016 | - | $5.03 M(-6.5%) |
| Dec 2015 | $5.38 M(+191.2%) | - |
| Dec 2015 | - | $5.38 M(-19.5%) |
| Sep 2015 | - | $6.68 M(+211.6%) |
| Jun 2015 | - | $2.14 M(+82.8%) |
| Mar 2015 | - | $1.17 M(-36.5%) |
| Dec 2014 | $1.85 M(+4892.4%) | - |
| Dec 2014 | - | $1.85 M(+349.7%) |
| Sep 2014 | - | $410.80 K(-16.8%) |
| Jun 2014 | - | $493.50 K(-45.9%) |
| Mar 2014 | - | $911.80 K(+2364.3%) |
| Dec 2013 | $37.00 K(+103.3%) | $37.00 K(+96.8%) |
| Sep 2013 | - | $18.80 K(-98.9%) |
| Jun 2013 | - | $1.74 M(-18.6%) |
| Mar 2013 | - | $2.14 M(>+9900.0%) |
| Dec 2012 | $18.20 K(-93.0%) | - |
| Dec 2012 | - | $18.20 K(-91.5%) |
| Sep 2012 | - | $214.30 K(-4.3%) |
| Jun 2012 | - | $223.90 K(-14.1%) |
| Mar 2012 | - | $260.60 K(+0.9%) |
| Dec 2011 | $258.30 K | - |
| Dec 2011 | - | $258.30 K(+699.7%) |
| Sep 2011 | - | $32.30 K |
FAQ
- What is Can-Fite BioPharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual total long term liabilities year-on-year change?
- What is Can-Fite BioPharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Can-Fite BioPharma?
- What is Can-Fite BioPharma quarterly long term liabilities year-on-year change?
What is Can-Fite BioPharma annual total long term liabilities?
The current annual total long term liabilities of CANF is $1.73 M
What is the all time high annual total long term liabilities for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual total long term liabilities is $5.38 M
What is Can-Fite BioPharma annual total long term liabilities year-on-year change?
Over the past year, CANF annual total long term liabilities has changed by -$583.00 K (-25.25%)
What is Can-Fite BioPharma quarterly total long term liabilities?
The current quarterly long term liabilities of CANF is $1.46 M
What is the all time high quarterly long term liabilities for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly total long term liabilities is $6.68 M
What is Can-Fite BioPharma quarterly long term liabilities year-on-year change?
Over the past year, CANF quarterly total long term liabilities has changed by -$469.00 K (-24.36%)